Edwards Lifesciences

EW64

S&P500

$66.81arrow_drop_up1.19%$0.79

S&P500

EW64

$66.81

arrow_drop_up1.19%$0.79

S&P500

Performance History

Key Stats
Open	$66.23
Prev. Close	$66.02
EPS	2.54
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	65.47	67.04
52 Week Range	58.93	96.12

Ratios







EPS	2.54

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Edwards Lifesciences (EW)

Edwards Lifesciences Corp (EW) is a global leader in advanced medical technologies, specializing in the development and manufacturing of heart valve systems and hemodynamic monitoring devices. The company's products are designed to treat patients with structural heart disease, as well as those in critical care settings. With a strong commitment to innovation and patient-centric solutions, Edwards Lifesciences Corp has revolutionized the field of cardiovascular care.

The stock price history of Edwards Lifesciences Corp reflects its success and growth. Over the years, the company has consistently delivered strong financial performance, driving the stock price higher. Investors have benefited from its steady appreciation and potential for long-term growth. The company's stock has experienced significant volatility at times, reflecting the inherent risks associated with the healthcare industry. However, Edwards Lifesciences Corp has consistently demonstrated its ability to overcome challenges and deliver value to its shareholders.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Bernard J. Zovighian
Headquarters: Irvine
Employees: 17300
Exchange: NYSE

Keep an eye on Edwards Lifesciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Edwards Lifesciences's (EW) price per share?

The current price per share for Edwards Lifesciences (EW) is $66.81. The stock has seen a price change of $0.79 recently, indicating a 1.2% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Edwards Lifesciences (EW)?

For Edwards Lifesciences (EW), the 52-week high is $96.12, which is 43.87% from the current price. The 52-week low is $58.93, the current price is 13.37% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Edwards Lifesciences (EW) a growth stock?

Edwards Lifesciences (EW) has shown an average price growth of 0.41% over the past three years. It has received a score of 54 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Edwards Lifesciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Edwards Lifesciences (EW) stock price performance year to date (YTD)?

As of the latest data, Edwards Lifesciences (EW) has a year-to-date price change of -11.59%. Over the past month, the stock has experienced a price change of 7.74%. Over the last three months, the change has been -23.8%. Over the past six months, the figure is -24.36%. Looking at a longer horizon, the five-year price change stands at -11.43%.

help

Is Edwards Lifesciences (EW) a profitable company?

Edwards Lifesciences (EW) has a net income of $1.4B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 77.02% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 27.22% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $6B, with a revenue growth rate of 11.56%, providing insight into the company's sales performance and growth. The gross profit is $4.62B. Operating income is noted at $1.53B. Furthermore, the EBITDA is $1.78B.

help

What is the market capitalization of Edwards Lifesciences (EW)?

Edwards Lifesciences (EW) has a market capitalization of $40.25B. The average daily trading volume is 5.92M, indicating the stock's liquidity and investor engagement.